Cutting costs on a pharmaceutical transformation project

GMP transformation: from device to veterinary medicine

For a product release to a south pacific market, Contura International needed to change the status of a medical device to veterinary medicine. Reduced costs, increased speed to market and a project plan based on GAP analysis and former reports were some of the major requirements. Based on Eltronic’s experience with QMS, LEAN and project management, Contura turned to Eltronic for the GMP transformation of the project.

A lean and pragmatic transition

Only a few batches of the pharmaceutical product are produced a year. Therefore, Eltronic needed to perform a lean and pragmatic transition from device QMS to GMP. Eltronic identified three central areas of investigation with potential for cost saving: raw material definition, the environmental monitoring strategy and GAP analysis.


Exceptions in the regulation

A thorough investigation led Eltronic to find exceptions of central importance in the regulations. The raw material for compounding the final product could be defined as starting material and the requirement for environmental monitoring could be lessened as the customer was producing veterinary medicines with terminal sterilization. Furthermore, Eltronic performed a GAP analysis of the existing QMS ensuring that only the required GMP procedures were added to the existing system.

Unexpected savings

Eltronic’s immense insights into the pharmaceutical rules and procedures enabled unexpected savings as the future control and analysis of receiving raw materials for the veterinary medicine was mitigated and the requirement for raw material audit was made redundant. The GAP analysis allowed transformation of the QMS into a fully GMP compliant system.


GMP transformation lead time

The transformation of Contura’s documentation and mindset - guided by Eltronic’s expertise - resulted in the project being completed in record time. As a final step, the inspection by the Danish Medicine Agency was successful.


Ongoing drug approval

Eltronic has been appointed qualified person (QP) for the ongoing drug release.

About Contura International

One of Contura's activities is to produce drugs for other pharmaceutical companies as a contract manufacturing organization (CMO). A company using Contura as CMO for their own brand, a polymer filler for veterinary purposes, was forced to register the medical device as veterinary medicine on specific markets. Contura was contractually obliged to see the transformations through and sponsor the project.

Contura International

The Steps of the Project

“Eltronic was able to act quickly, competently and professionally. The transformation was in safe hands and during the process we never doubted the final result! And we were right!”


Maibrit Søe (QA Director) and Lars Trolle (CEO) at Contura International

In need of a Qualified Person?

Interested in improving your pharma project?

Do you have a complex QMS or GMP task that you are unsure how to solve? Please contact me for a talk about how we can help you optimize your production and reduce costs.


Boe Boesen

Director, Pharma Engineering